An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow

Acute graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation is the most significant limiting factor preventing the widespread application of transplant therapy in acute leukemia and aplastic anemia. GVHD is mediated by T cells that contaminate harvested marrow in proporti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer drug delivery 1983, Vol.1 (1), p.79-86
Hauptverfasser: Ozer, H, Han, T, Early, A, O'Leary, M, Thompson, D, Dadey, B, Cohen, N, Higby, D J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 86
container_issue 1
container_start_page 79
container_title Cancer drug delivery
container_volume 1
creator Ozer, H
Han, T
Early, A
O'Leary, M
Thompson, D
Dadey, B
Cohen, N
Higby, D J
description Acute graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation is the most significant limiting factor preventing the widespread application of transplant therapy in acute leukemia and aplastic anemia. GVHD is mediated by T cells that contaminate harvested marrow in proportions ranging from 5-50% of the mononuclear cell population. T cell depletion (TCD) of large volumes of human marrow by E-rosetting for 24 h at 4 degrees C with modified sheep erythrocytes achieves removal of greater than or equal to 97% of all T cells, as judged by cytofluorographic analysis of the T-depleted bone marrow population with a broad panel of anti-T cell monoclonal antibodies, and abrogates functional T cell activity. Although T-depleted bone marrow cell recoveries were 2 logs below total harvested buffy coat cell numbers, the TCD mononuclear population was more than 99% viable and was enriched twofold for Ia+ cells as judged by cytofluorographic analysis. This method is at least the equivalent of those employing lectin column or monoclonal antibody/complement lysis techniques and is simpler to perform. Successful engraftment of adult patients can safely be obtained with as few as 4 X 10(8) total mononuclear cells following the 24-h procedure suggesting that prolonged or repeated T-depletion procedures do not interfere with stem cell engraftment. Preliminary results suggest that this method of TCD may ameliorate GVHD in histoincompatible transplants.
doi_str_mv 10.1089/cdd.1983.1.79
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80971223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80971223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c244t-a7acb3d7d2d3d924dd92fad8973dcccb32b4c0cc25efeae8126a80fb57f1869d3</originalsourceid><addsrcrecordid>eNo9kD1PwzAQhj2ASimMjEie2FL8kcT2WFV8SZVYysBkOfaZGiVxiFMQ_x5XrVjuhnvu1d2D0A0lS0qkurfOLamSfEmXQp2hORGcFaqU7AJdpvRJSF0JSmZoVnOlZFXP0fuqx6EbxvgNDncw7aLDPo54W1hoW-xgaGEKscfRY9O28QN6CBbvQppi6G3sBjOFpgXsYp_XmtgD7sw4xp8rdO5Nm-D61Bfo7fFhu34uNq9PL-vVprCsLKfCCGMb7oRjjjvFSpeLN04qwZ21ecSa0hJrWQUeDEjKaiOJbyrhqayV4wt0d8zNT3ztIU26C-lwvOkh7pOWRAnKGM9gcQTtGFMawethDPnWX02JPujTWZ8-6NNUC5X521PwvunA_dMnd_wPZStv7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80971223</pqid></control><display><type>article</type><title>An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Ozer, H ; Han, T ; Early, A ; O'Leary, M ; Thompson, D ; Dadey, B ; Cohen, N ; Higby, D J</creator><creatorcontrib>Ozer, H ; Han, T ; Early, A ; O'Leary, M ; Thompson, D ; Dadey, B ; Cohen, N ; Higby, D J</creatorcontrib><description>Acute graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation is the most significant limiting factor preventing the widespread application of transplant therapy in acute leukemia and aplastic anemia. GVHD is mediated by T cells that contaminate harvested marrow in proportions ranging from 5-50% of the mononuclear cell population. T cell depletion (TCD) of large volumes of human marrow by E-rosetting for 24 h at 4 degrees C with modified sheep erythrocytes achieves removal of greater than or equal to 97% of all T cells, as judged by cytofluorographic analysis of the T-depleted bone marrow population with a broad panel of anti-T cell monoclonal antibodies, and abrogates functional T cell activity. Although T-depleted bone marrow cell recoveries were 2 logs below total harvested buffy coat cell numbers, the TCD mononuclear population was more than 99% viable and was enriched twofold for Ia+ cells as judged by cytofluorographic analysis. This method is at least the equivalent of those employing lectin column or monoclonal antibody/complement lysis techniques and is simpler to perform. Successful engraftment of adult patients can safely be obtained with as few as 4 X 10(8) total mononuclear cells following the 24-h procedure suggesting that prolonged or repeated T-depletion procedures do not interfere with stem cell engraftment. Preliminary results suggest that this method of TCD may ameliorate GVHD in histoincompatible transplants.</description><identifier>ISSN: 0732-9482</identifier><identifier>DOI: 10.1089/cdd.1983.1.79</identifier><identifier>PMID: 6399856</identifier><language>eng</language><publisher>United States</publisher><subject>Bone Marrow - immunology ; Bone Marrow Cells ; Bone Marrow Transplantation ; Cell Separation - methods ; Cell Survival ; Colony-Forming Units Assay ; Graft vs Host Disease - prevention &amp; control ; Hematopoietic Stem Cells - cytology ; Humans ; Rosette Formation ; T-Lymphocytes - immunology ; Transplantation, Homologous</subject><ispartof>Cancer drug delivery, 1983, Vol.1 (1), p.79-86</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c244t-a7acb3d7d2d3d924dd92fad8973dcccb32b4c0cc25efeae8126a80fb57f1869d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6399856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozer, H</creatorcontrib><creatorcontrib>Han, T</creatorcontrib><creatorcontrib>Early, A</creatorcontrib><creatorcontrib>O'Leary, M</creatorcontrib><creatorcontrib>Thompson, D</creatorcontrib><creatorcontrib>Dadey, B</creatorcontrib><creatorcontrib>Cohen, N</creatorcontrib><creatorcontrib>Higby, D J</creatorcontrib><title>An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow</title><title>Cancer drug delivery</title><addtitle>Cancer Drug Deliv</addtitle><description>Acute graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation is the most significant limiting factor preventing the widespread application of transplant therapy in acute leukemia and aplastic anemia. GVHD is mediated by T cells that contaminate harvested marrow in proportions ranging from 5-50% of the mononuclear cell population. T cell depletion (TCD) of large volumes of human marrow by E-rosetting for 24 h at 4 degrees C with modified sheep erythrocytes achieves removal of greater than or equal to 97% of all T cells, as judged by cytofluorographic analysis of the T-depleted bone marrow population with a broad panel of anti-T cell monoclonal antibodies, and abrogates functional T cell activity. Although T-depleted bone marrow cell recoveries were 2 logs below total harvested buffy coat cell numbers, the TCD mononuclear population was more than 99% viable and was enriched twofold for Ia+ cells as judged by cytofluorographic analysis. This method is at least the equivalent of those employing lectin column or monoclonal antibody/complement lysis techniques and is simpler to perform. Successful engraftment of adult patients can safely be obtained with as few as 4 X 10(8) total mononuclear cells following the 24-h procedure suggesting that prolonged or repeated T-depletion procedures do not interfere with stem cell engraftment. Preliminary results suggest that this method of TCD may ameliorate GVHD in histoincompatible transplants.</description><subject>Bone Marrow - immunology</subject><subject>Bone Marrow Cells</subject><subject>Bone Marrow Transplantation</subject><subject>Cell Separation - methods</subject><subject>Cell Survival</subject><subject>Colony-Forming Units Assay</subject><subject>Graft vs Host Disease - prevention &amp; control</subject><subject>Hematopoietic Stem Cells - cytology</subject><subject>Humans</subject><subject>Rosette Formation</subject><subject>T-Lymphocytes - immunology</subject><subject>Transplantation, Homologous</subject><issn>0732-9482</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kD1PwzAQhj2ASimMjEie2FL8kcT2WFV8SZVYysBkOfaZGiVxiFMQ_x5XrVjuhnvu1d2D0A0lS0qkurfOLamSfEmXQp2hORGcFaqU7AJdpvRJSF0JSmZoVnOlZFXP0fuqx6EbxvgNDncw7aLDPo54W1hoW-xgaGEKscfRY9O28QN6CBbvQppi6G3sBjOFpgXsYp_XmtgD7sw4xp8rdO5Nm-D61Bfo7fFhu34uNq9PL-vVprCsLKfCCGMb7oRjjjvFSpeLN04qwZ21ecSa0hJrWQUeDEjKaiOJbyrhqayV4wt0d8zNT3ztIU26C-lwvOkh7pOWRAnKGM9gcQTtGFMawethDPnWX02JPujTWZ8-6NNUC5X521PwvunA_dMnd_wPZStv7g</recordid><startdate>1983</startdate><enddate>1983</enddate><creator>Ozer, H</creator><creator>Han, T</creator><creator>Early, A</creator><creator>O'Leary, M</creator><creator>Thompson, D</creator><creator>Dadey, B</creator><creator>Cohen, N</creator><creator>Higby, D J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1983</creationdate><title>An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow</title><author>Ozer, H ; Han, T ; Early, A ; O'Leary, M ; Thompson, D ; Dadey, B ; Cohen, N ; Higby, D J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c244t-a7acb3d7d2d3d924dd92fad8973dcccb32b4c0cc25efeae8126a80fb57f1869d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Bone Marrow - immunology</topic><topic>Bone Marrow Cells</topic><topic>Bone Marrow Transplantation</topic><topic>Cell Separation - methods</topic><topic>Cell Survival</topic><topic>Colony-Forming Units Assay</topic><topic>Graft vs Host Disease - prevention &amp; control</topic><topic>Hematopoietic Stem Cells - cytology</topic><topic>Humans</topic><topic>Rosette Formation</topic><topic>T-Lymphocytes - immunology</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozer, H</creatorcontrib><creatorcontrib>Han, T</creatorcontrib><creatorcontrib>Early, A</creatorcontrib><creatorcontrib>O'Leary, M</creatorcontrib><creatorcontrib>Thompson, D</creatorcontrib><creatorcontrib>Dadey, B</creatorcontrib><creatorcontrib>Cohen, N</creatorcontrib><creatorcontrib>Higby, D J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer drug delivery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozer, H</au><au>Han, T</au><au>Early, A</au><au>O'Leary, M</au><au>Thompson, D</au><au>Dadey, B</au><au>Cohen, N</au><au>Higby, D J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow</atitle><jtitle>Cancer drug delivery</jtitle><addtitle>Cancer Drug Deliv</addtitle><date>1983</date><risdate>1983</risdate><volume>1</volume><issue>1</issue><spage>79</spage><epage>86</epage><pages>79-86</pages><issn>0732-9482</issn><abstract>Acute graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation is the most significant limiting factor preventing the widespread application of transplant therapy in acute leukemia and aplastic anemia. GVHD is mediated by T cells that contaminate harvested marrow in proportions ranging from 5-50% of the mononuclear cell population. T cell depletion (TCD) of large volumes of human marrow by E-rosetting for 24 h at 4 degrees C with modified sheep erythrocytes achieves removal of greater than or equal to 97% of all T cells, as judged by cytofluorographic analysis of the T-depleted bone marrow population with a broad panel of anti-T cell monoclonal antibodies, and abrogates functional T cell activity. Although T-depleted bone marrow cell recoveries were 2 logs below total harvested buffy coat cell numbers, the TCD mononuclear population was more than 99% viable and was enriched twofold for Ia+ cells as judged by cytofluorographic analysis. This method is at least the equivalent of those employing lectin column or monoclonal antibody/complement lysis techniques and is simpler to perform. Successful engraftment of adult patients can safely be obtained with as few as 4 X 10(8) total mononuclear cells following the 24-h procedure suggesting that prolonged or repeated T-depletion procedures do not interfere with stem cell engraftment. Preliminary results suggest that this method of TCD may ameliorate GVHD in histoincompatible transplants.</abstract><cop>United States</cop><pmid>6399856</pmid><doi>10.1089/cdd.1983.1.79</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-9482
ispartof Cancer drug delivery, 1983, Vol.1 (1), p.79-86
issn 0732-9482
language eng
recordid cdi_proquest_miscellaneous_80971223
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Bone Marrow - immunology
Bone Marrow Cells
Bone Marrow Transplantation
Cell Separation - methods
Cell Survival
Colony-Forming Units Assay
Graft vs Host Disease - prevention & control
Hematopoietic Stem Cells - cytology
Humans
Rosette Formation
T-Lymphocytes - immunology
Transplantation, Homologous
title An improved method for T-cell depletion of allogeneic histoincompatible donor bone marrow
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20improved%20method%20for%20T-cell%20depletion%20of%20allogeneic%20histoincompatible%20donor%20bone%20marrow&rft.jtitle=Cancer%20drug%20delivery&rft.au=Ozer,%20H&rft.date=1983&rft.volume=1&rft.issue=1&rft.spage=79&rft.epage=86&rft.pages=79-86&rft.issn=0732-9482&rft_id=info:doi/10.1089/cdd.1983.1.79&rft_dat=%3Cproquest_cross%3E80971223%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80971223&rft_id=info:pmid/6399856&rfr_iscdi=true